<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Molecular Microbiology (2009) 74(3), 529&#226;&#8364;&#8220;540 &#228;&#352;?                                               doi:10.1111/j.1365-2958.2009.06761.x <br />                                                                                               published online 24 June 2009 <br />  <br />  <br />  <br /> Dissecting essentiality bifunctional trypanothione <br /> synthetase-amidase Trypanosoma brucei using <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>chemical</span> genetic methods                          mmi_6761 529..540 <br />  <br />  <br />  <br />  <br /> Susan Wyllie, Sandra L. Oza, Stephen Patterson,                    Introduction <br /> Daniel Spinks, Stephen Thompson Alan H. Fairlamb*                                                  protozoan parasite Trypanosoma brucei caus- <br /> Division Biological Chemistry Drug Discovery,               ative agent human African trypanosomiasis (HAT), <br /> Wellcome Trust Biocentre, College Life Sciences,                commonly known sleeping sickness. disease, <br /> University Dundee, Dundee, DD1 5EH, Scotland, UK.               thought largely controlled 1960s,                                                                    emerged major threat human health                                                                    number factors including lack financial resources, <br /> Summary                                                            conflict affected countries failure adequately <br />                                                                    monitor infection. Currently, World Health Organisa- bifunctional trypanothione synthetase-amidase <br />                                                                    tion reports 400 000 people infected (TRYS) comprises structurally distinct catalytic <br />                                                                    HAT, resulting annual death toll domains synthesis hydrolysis trypan- <br />                                                                    50 000 (Stuart et al., 2008). absence effec- <br /> othione (N 1,N 8-bis(glutathionyl)<span id='am-53' about='obo:IMR_0200175' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-54' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:id" content="IMR:0200175" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasDbXref" content="KEGG:C00315" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="Spermidine" datatype="xsd:string"></span>spermidine</span>).                                                                    tive vaccine, treatment solely dependent piti- <br /> unique dithiol plays pivotal role thiol-redox <br />                                                                    fully small repertoire drugs suffer homeostasis defence chemical                                                                    number problems including severe toxic effects <br /> oxidative stress trypanosomatids. tetracycline- <br />                                                                    (Fairlamb, 2003) acquired drug resistance (Barrett <br /> dependent conditional double knockout TRYS <br />                                                                    Fairlamb, 1999). compound difficulties, <br /> (cDKO) generated bloodstream Trypanosoma <br />                                                                    current chemotherapeutic treatments brucei. Culture cDKO parasites tetracycline <br />                                                                    require lengthy periods hospitalization pro- <br /> induction resulted loss trypanothione accu- <br />                                                                    hibitively expensive (Stuart et al., 2008). new <br /> mulation <span id='am-25' about='obo:IMR_0100173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001700'><span id='am-26' property="obo:IAO_0000115" content="A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides." datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="glutathione" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasExactSynonym" content="L-Glutathione" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="L-Glutathione" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasExactSynonym" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasExactSynonym" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:id" content="IMR:0100173" datatype="xsd:string"></span><span id='am-36' property="rdfs:label" content="Reduced glutathione" datatype="xsd:string"></span>glutathione</span>, followed growth inhibition <br />                                                                    drugs treatment HAT pipeline,  cell lysis 6 days. absence inducer, <br />                                                                    certed effort identify, characterize cDKO cells unable infect mice, confirming                                                                    validate novel molecular targets urgently required enzyme essential virulence vivo                                                                    drug discovery. vitro. establish enzymatic functions <br />                                                                       search anti-parasitic drug targets, metabolic essential, amidase-dead mutant cDKO line <br />                                                                    pathways essential parasite survival generated. presence inducer, line <br />                                                                    absent host logical starting points (El <br /> showed decreased growth vitro decreased viru- <br />                                                                    Sayed et al., 2005). pathway thiol <br /> lence vivo, indicating amidase function                                                                    metabolism trypanosomes Leishmania. absolutely required viability. druggability <br />                                                                    parasites uniquely dependent trypanothione TRYS assessed using potent small molecule <br />                                                                    (N 1,N 8-bis(glutathionyl)spermidine, T[SH]2) prin- <br /> inhibitor developed laboratory. Growth inhibi- <br />                                                                    cipal thiol, contrast organisms (including <br /> tion correlated rank order cDKO, single KO, wild- <br />                                                                    mammalian hosts) utilize <span id='am-58' about='obo:IMR_0200318' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-59' property="oboInOwl:id" content="IMR:0200318" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-61' property="rdfs:label" content="Glutathione" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>glutathione</span> (g-L- <br /> type overexpressing lines produced                                                                    glutamyl-L-cysteinylglycine, GSH) (Fairlamb et al., 1985). <br /> predicted biochemical phenotype. synthetase <br />                                                                    dithiol primarily responsible maintenance <br /> function TRYS unequivocally validated                                                                    thiol-redox homeostasis trypanosomatids, drug target chemical genetic methods. <br />                                                                    involved number critical cellular processes <br />                                                                    including deoxyribonucleotide synthesis (Dormeyer <br /> Accepted 3 June, 2009.  correspondence. E-mail h.fairlamb@   et al., 2001), defence oxidative stress (Ariy- <br /> dundee.ac.uk; Tel. (+44) 1382 38 5155; Fax (+44) 1382 38 5542.     anayagam Fairlamb, 2001) xenobiotics (Vickers use article permitted accordance Terms Conditions set http://www3.interscience.wiley.com/      et al., 2004). Trypanothione implicated <br /> authorresources/onlineopen.html                                    mode action mechanism &#194;&#169; 2009 Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing  530 S. Wyllie et al. &#228;&#352;? <br />  <br /> resistance antimonial drugs Leishmania spp.                 Results discussion <br /> (Mukhopadhyay et al., 1996; Wyllie et al., 2004; Croft <br /> et al., 2006) defence chemical                 Generation TRYS conditional null mutants <br /> oxidant stress induced arsenicals nifurtimox            <span id='am-5' about='oboInOwl:date' typeof='owl:Thing'>date</span>, essentiality T. brucei trypanothione syn- <br /> T. brucei (Fairlamb et al., 1989; Ariyanayagam et al.,            thetase (TRYS) demonstrated RNAi <br /> 2005; Alibu et al., 2006).  attempt            (Comini et al., 2004; Ariyanayagam et al., 2005), meth- <br /> exploit essential unique metabolite, T[SH]2-             odology lacks robustness classical gene <br /> dependent biosynthetic enzymes                  replacement. mind, sought definitively <br /> major focus drug discovery.                                   classify enzyme drug target bloodstream try- <br />    pivotal role T[SH]2 metabolism viability     panosomes replacing TRYS drug-resistance <br /> virulence trypanosomatids unequivocally               genes (Fig. 1A). Previous studies demonstrated demonstrated using genetic techniques classical           TRYS present single-copy gene haploid <br /> gene knockout RNA interference (RNAi).                        genome T. brucei (Oza et al., 2003). TRYS <br /> Trypanothione-dependent enzymes vali-              gene copy replaced puromycin N-acetyl <br /> dated potential drug targets using methodologies         transferase (PAC) gene homologous recombination <br /> include: trypanothione reductase (Tovar et al., 1998;             subsequent selection puromycin resistance, gen- <br /> Krieger et al., 2000), tryparedoxin (Wilkinson et al., 2003)      erating single knockout (SKO) cell line. Attempts tryparedoxin peroxidase (Wilkinson et al., 2003).             create null mutant directly replacing second <br /> Unsurprisingly, enzyme responsible biosynthe-         allelic copy hygromycin-resistance gene (hygro- <br /> sis T[SH]2, bifunctional trypanothione synthetase-         mycin phosphotransferase, HYG) proved unsuccessful, <br /> amidase (TRYS), confirmed essential              suggesting TRYS essential viability viability proliferation T. brucei bloodstream      T. brucei bloodstream parasites. Consequently,  <br /> (Comini et al., 2004) procyclic forms (Ariyanayagam           ditional double knockout (cDKO) cell line generated <br /> et al., 2005) RNAi. pathogenic trypanosomatids,             introducing ectopic tetracycline-inducible copy <br /> TRYS catalyses synthesis T[SH]2 GSH               TRYS prior replacing second copy HYG. <br /> spermidine step, <span id='am-37' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-38' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-44' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-47' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span>ATP</span>-dependent reaction            ectopic copy TRYS inserted rDNA <br /> glutathionylspermidine intermediate. addition          locus SKO cell line using pLew 100 vector encod- <br /> role biosynthesis, N-terminal domain TRYS          ing blasticidin-resistance gene (BSD) followed dele- <br /> functions amidase, hydrolysing T[SH]2 GSH            tion second genomic copy HYG. spermidine, glutathionylspermidine. bio-            modified T. brucei 427 cell line [wild-type (WT)] used logical significance TRYS-amidase, classified             study constitutively expresses T7 RNA poly- <br /> cysteine&#226;&#8364;&#8220;histidine-dependent aminohydrolase/peptidase             merase tetracycline repressor protein, result- <br /> amidase (Bateman Rawlings, 2003; Rigden et al.,               ing cell line TRYS conditional null mutant 2003), fully understood.  sug-         TRYS expression depends presence tetracy- <br /> gested conflicting biosynthetic hydrolytic           cline (cDKO). Southern blot analysis genomic DNA <br /> functions enzyme enable parasite               cell lines generated stage process <br /> respond fluctuating cellular requirements             confirmed validity TRYS conditional null mutant <br /> T[SH]2 polyamines, essential proliferation dif-       (Fig. 1B). <br /> ferentiation (Fairlamb Cerami, 1992; Bacchi Yarlett, 1995). <br />                                                                   TRYS essential bloodstream T. brucei vitro <br />    current study, assessed essentiality TRYS classical gene replacement fulfil stringent        HMI9-T culture medium, significant difference target validation criteria University Dundee Drug       detected growth rates WT SKO <br /> Discovery Unit (Frearson et al., 2007). Gene replacement          cells, generation times 9.6 &#226;&#171;&#190; 0.1 9.5 &#226;&#171;&#190; 0.2 h preferred method genetic validation             respectively (data shown).  cDKO cell line, <br /> &#226;&#8364; target&#226;&#8364;&#8482; effects ruled using RNAi.         grown presence tetracycline, showed marked  target knock RNAi does permit inde-             growth phenotype doubling time 9.9 &#226;&#171;&#190; 0.02 h <br /> pendent analysis bifunctional enzymes                  (Fig. 2A). Following removal tetracycline DHFR-TS (Sienkiewicz et al., 2008) TRYS. Using               medium, cDKO cells continued grow exponentially combination classical gene replacement, mutagenesis            3 days. Growth slowed day 4 culture cells chemical intervention methods, dissect oppos-          finally dying day 8. determine actual point ing synthetic hydrolytic functions TRYS order        cDKO parasites grown absence tetracycline com- <br /> independently study respective roles T. brucei cell      pletely lose viability, cells subcultured day virulence viability.                                          medium containing tetracycline. 6th day  <br />                                                                                                               &#194;&#169; 2009 Authors <br />                                          Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                                    Synthetase amidase activity TRYS essential 531 <br />  <br />                                1st allele                                    cytostatic highly advantageous drug discovery <br />                       5&#226;&#8364;&#178;                              3&#226;&#8364;&#178; <br />                                     TRYS                                         perspective drug therapy dependent                                                                                fully functional immune response (Frearson et al., 2007). <br />                                          PAC <br />  <br />                                                                                Biochemical analyses TRYS cDKO cells <br />                                        500 bp <br />                                                                                &#226;&#8364;&#732;slow death&#226;&#8364;&#8482; phenotype cDKO cells following                                     rDNA                                       removal tetracycline partly explained low <br />                               PARP <br />                                                                                turnover TRYS product, T[SH]2. Western blot <br />  ii                           Promoter                                         analysis cell extracts revealed                      T7       TetR                                             levels enzyme declined following removal                      Promoter Operator <br />              rDNA   BSD                        TRYS             rDNA           tetracycline, day 6 TRYS                                                                                longer detectable (Fig. 2B). observation suggests <br />                                                                                rate turnover TRYS  T[SH]2) low                                  2st allele <br />                                   TRYS                                         T. brucei TRYS  T[SH]2) removed  iii                                                                           cell dilution cell division absence                                        HYG                                     protein synthesis.  death                                                                                cDKO cells coinciding disappearance TRYS <br />                                                                                confirms enzyme essential  B             1          2        3           4                               bloodstream trypanosomes. <br />                                                                                   effect TRYS depletion intracellular thiols        kb                                                                      studied high-performance liquid chromatography <br />        12 <br />                                                            ectopic TbTRYS      (HPLC). number cells required analy- <br />         7 <br />         5 <br />         4                                                                      sis, thiols monitored cultures 4 days <br />         3                                                  endogenous TbTRYS <br />                                                                                following removal tetracycline. cessation          2 <br />        1.6                                                                     ectopic TRYS expression parasites                                                                                pronounced effect intracellular thiol levels (Fig. 2C). <br />                                                                                Glutathione, substrate TRYS, accumulated cDKO <br /> Fig. 1. Genotypic analysis WT, SKO cDKO cell lines.                     cells absence tetracycline, 4 days,  Schematic representation stepwise generation TRYS cDKO cell line T. brucei.   allele TRYS                   levels reach 160% seen control cells <br /> replaced puromycin-resistance gene (PAC) homologous                (cDKO cells plus tetracycline). contrast, T[SH]2 recombination, generating DTRYS::PAC cell line (SKO); (ii)                   glutathionylspermidine, products enzyme reac- <br /> tetracycline-inducible ectopic copy TRYS introduced rDNA, generating TRYS TiDTRYS::PAC cell line; (iii)                      tion, fell considerably.  T[SH]2 levels tetracycline induces expression ectopic copy,                   parasites fell 16.5% control levels. 4 day cultures <br /> remaining allele replaced hygromycin resistance gene                showed minimally retarded growth comparison <br /> (HYG) homologous recombination, resulting conditional <br /> double knockout cell line TRYS TiDTRYS::PAC/DTRYS::HYG                         control cells, appear bloodstream trypa- <br /> (cDKO).                                                                        nosomes, vitro, survive vanishingly <br /> B. Confirmation genotype T. brucei TRYS conditional double               small amounts T[SH]2.  noted knockout cell line. Southern blot analysis PstI-digested genomic <br /> DNA (~5 mg) wild-type T. brucei cells (lane 1), DTRYS::PAC                HMI9-T culture medium used studies rich (lane 2), TRYS TiDTRYS::PAC (lane 3)                                       reducing agents thioglycerol (56 mM) cys- <br /> TRYS TiDTRYS::PAC/DTRYS::HYG (lane 4) cells; TRYS ORF                      teine (1.5 mM) protect thiol-depleted <br /> probe shows allelic TbTRYS 3 kb ectopic copy <br /> TbTRYS Ti ~10 kb.                                                           cells oxidant stress. <br />  <br />  <br />                                                                                Virulence cDKO parasites mice <br /> culture cells remained viable absence tetracy- <br /> cline;  point viable cDKO cells                         oxidative environment vivo significantly different recovered culture 10 days.                           vitro culture conditions, underlining importance <br /> Failure cell line grow absence                        carrying drug target validation studies appropri- <br /> tetracycline-induced expression TRYS confirms                          ate animal models (Frearson et al., 2007). enzyme essential bloodstream T. brucei viability.                  mind, groups mice inoculated WT, cDKO Interestingly, ectopic expression L. major TRYS                         cDKO parasites grown absence equally capable complementing loss                           tetracycline 24 h. Mice infected tetracycline- <br /> endogenous TRYS cDKO cell line (Fig. S1).                           treated parasites dosed doxycycline fact loss TRYS activity trypanocidal                    drinking water 5 days prior  infection  <br /> &#194;&#169; 2009 Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />  532 S. Wyllie et al. &#228;&#352;? <br />                                1e11                                                          B <br />                                 1e10 <br /> Cumulative cell numbers, ml-1 <br />  <br />  <br />                                  1e9 <br />  <br />                                  1e8 <br />                                                                                               TRYS <br />                                  1e7 <br />  <br />                                  1e6 <br />                                                                                               PTR1 <br />                                  1e5                                                                    WT        cDKO        SKO       cDKO         cDKO cDKO <br />                                 10000                                                                             + TET                 -TET         -TET -TET <br />                                                                                                                                         Day 2        Day 4 Day 6 <br />                                 1000 <br />  <br />                                  100 <br />  <br />                                         0   2     4          6   8 <br />                                                 Time, days <br />  <br />                                                                  C                      180 <br />  <br />                                                                                         160 <br />  <br />                                                                                         140 <br />                                                                  Thiols, % control <br />  <br />  <br />  <br />  <br />                                                                                         120 <br />  <br />                                                                                         100 <br />  <br />                                                                                         80 <br />  <br />                                                                                         60 <br />  <br />                                                                                         40 <br />  <br />                                                                                         20 <br />  <br />                                                                                          0 <br />  <br />                                                                                               0          2                4 <br />                                                                                                      Time, days <br />  <br /> Fig. 2. Growth characteristics biochemical analysis cDKO cells vitro.  growth cDKO cell line HMI9-T media monitored presence (closed circles) absence tetracycline (open circles, <br /> dashed line). arrow indicates point viable cells longer recoverable subcultured 10 days medium <br /> containing tetracycline. <br /> B. Immunoblots cell extracts WT, SKO cDKO (plus minus tetracycline) cells probed antiserum T. brucei TRYS T. brucei PTR1 control (1 &#194;&#165; 107 parasites lane). <br /> C. Intracellular T[SH]2 (closed circles) GSH (open circles) levels cDKO cells following removal tetracycline cultures. Initial <br /> levels T[SH]2 GSH untreated cells 0.42 0.54 nmol(108 cells)-1 respectively. data point represents means &#226;&#171;&#190; standard deviations triplicate determinations. <br />  <br />  <br /> maintain expression ectopic TRYS. Infections                                                     mutants essential genes T. brucei (Chang et al., <br /> monitored 30 day period survival curves                                                    2002; Roper et al., 2002). Collectively, results infection shown Fig. 3. Mice infected WT                                                confirm TRYS essential parasite survival parasites succumbed infection day 5                                                   mammalian host. case mice infected cells expressing <br /> ectopic TRYS (cDKO plus doxycycline). contrast,                                                                                                          Chemical validation TRYS drug target mice infected cDKO cells absence                                                                                                          T. brucei <br /> doxycycline remained completely free parasites 30 days remaining mouse                                                       Genetic validation crucial step identification <br /> group showed lethal parasitaemia day 23.                                                       drug target.  importance demonstrat- <br /> Western blot analysis cells recovered infected                                              ing target &#226;&#8364;&#732;druggable&#226;&#8364;&#8482; cell mouse confirmed parasites regained                                                        underestimated. result high-throughput drug <br /> expression TRYS, suggesting tetracycline control                                                 screening medicinal chemistry campaign carried lost, common phenomenon conditional null                                                   Drug Discovery Unit Dundee, DDU 86439 (N-(3- <br />  <br />                                                                                                                                       &#194;&#169; 2009 Authors <br />                                                                  Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                            Synthetase amidase activity TRYS essential 533 <br />  <br />                                                                        (14 mM) maintain 5% original <br />                    100                                                 T[SH]2 levels 72 h. case cDKO cells <br />                                                                        (Fig. 2B), absence functional TRYS drug-treated <br />                                                                        cells led accumulation GSH, levels reaching <br />                     80                                                 fourfold higher seen untreated cells.                                                                        greater speed magnitude effects consis- <br />      Survival, % <br />  <br />  <br />  <br />  <br />                                                                        tent acute effects chemical inhibition compared <br />                     60 <br />                                                                        slower effects loss target activity genetic <br />                                                                        intervention (Fig. 2D). observations suggest <br />                     40                                                 minimum concentration T[SH]2 compatible                                                                        survival ~3 mM [Table S3, assuming 108 cells = 5.8 ml <br />                                                                        (Opperdoes et al., 1984)]. <br />                     20 <br />  <br />                                                                        amidase activity TRYS essential                      0                                                 bloodstream T. brucei? <br />                          0   10             20             30 <br />                                                                        Following unequivocal chemical genetic valida- <br />                                   Time, days <br />                                                                        tion synthetase activity TRYS drug target Fig. 3. Virulence cDKO parasites mice. Groups mice       bloodstream T. brucei, posed question: infected WT cDKO cells (1 &#194;&#165; 104 parasites).        bifunctional enzyme actually embody drug targets Mice infected tetracycline-treated parasites dosed                                                                         Comparatively little known amidase <br /> doxycycline drinking water 3 days prior   infection. Data presented form Kaplan&#226;&#8364;&#8220;Meier        activity TRYS biological function remains <br /> survival plot. Symbols: WT, blue; cDKO presence              unclear. previous kinetic structural studies, cys- <br /> doxycycline, red; cDKO absence doxycycline, green. <br />                                                                        teine position 59 equivalent Crithidia fasiculata <br />                                                                        (Oza et al., 2002a) L. major (Fyfe et al., 2008) <br /> (dimethylamino)propyl)-2-(3-(3-fluorophenyl)-1H-indazol-               enzymes demonstrated critical cata- <br /> 1-yl)acetamide, Fig. 4A) identified potent inhibi-            lytic mechanism TRYS-amidase. Replacement tor recombinant T. brucei TRYS IC50 45 nM                cysteine 59 alanine Crithidia enzyme <br />  details published . com-                resulted functional synthetase devoid amidase <br /> pound inhibited growth WT cells HMI9-T media                 activity. determine role TRYS-amidase para- EC50 value 7.0 &#226;&#171;&#190; 0.2 mM following 72 h                    site viability virulence, knowledge exploited <br /> exposure. confirm TRYS specifically targeted               generate TRYS conditional null mutant cell line compound, TRYS SKO overexpressing (OE)                     (cDKO(C57A)) expressing amidase-&#226;&#8364;&#732;dead&#226;&#8364;&#8482; enzyme <br /> cell lines compared WT cells relative              tetracycline control (Fig. S3). <br /> sensitivity compound DDU 86439. Western analysis                       amidase dead cell line viable HMI9-T densitometry demonstrated TRYS protein levels                 medium presence tetracycline generation approximately twofold lower SKO cells (Fig. 2B)                time 11.1 &#226;&#171;&#190; 0.1 h (Fig. 5A), marginally slower threefold higher OE cells compared WT                   original cDKO line (9.9 &#226;&#171;&#190; 0.02 h). Removal tetracycline <br /> levels (Fig. S2). Changes level TRYS                resulted slow death parasites 8 day <br /> cells correlated relative sensitivity com-          period viability lost day 6 culture,  <br /> pound DDU 86439 EC50 values 1.2 &#226;&#171;&#190; 0.04                     firming TRYS synthetase, amidase activity 23.0 &#226;&#171;&#190; 0.4 mM SKO OE cell lines respectively                   essential growth vitro. identical manner (Fig. 4B). cDKO cells, grown absence tetracy-                cDKO cell line, intracellular T[SH]2 levels fell following cline 2 days prior analysis, hyper-            removal tetracycline cDKO(C57A) cultures sensitive compound (EC50 0.46 &#226;&#171;&#190; 0.01 mM,                       GSH steadily accumulated (Fig. 5B). Parasites express- <br /> Fig. 4B), providing evidence TRYS spe-             ing amidase-dead TRYS markedly virulent <br /> cific target inhibitor.                                        mice expressing functional enzyme <br />    Intracellular thiol levels determined WT para-              (Fig. 5C). mice infected cDKO(C57A) gradu- <br /> sites following incubation concentrations TRYS             ally succumbed infection 9 day period, day <br /> inhibitor corresponding 0.5, 1.0, 1.5 2.0 times             6&#226;&#8364;&#8220;15, cDKO-infected animals died day 5. established EC50 value (7 mM) (Fig. 4C). Treatment                parasites recovered cDKO(C57A)-infected mice  <br /> DDU 86439 resulted significant, dose-dependent                    tinued express mutated form TRYS enzyme, <br /> decrease levels intracellular T[SH]2. Trypano-               determined PCR sequence analysis genomic <br /> somes incubated highest levels compound               DNA (data shown). mice infected  <br /> &#194;&#169; 2009 Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />  534 S. Wyllie et al. &#228;&#352;? <br />  <br />                                                               <br />  <br />  <br />  <br />                B                                                            C <br />                                100                                                              400 <br />  <br />  <br />                                80 <br />                                                                                                 300 <br />  <br />  <br />  <br />  <br />                                                                             Thiols, % control <br />                Cell count, % <br />  <br />  <br />  <br />  <br />                                60 <br />  <br />                                                                                                 200 <br />                                40 <br />  <br />  <br />                                                                                                 100 <br />                                20 <br />  <br />  <br />  <br />                                 0                                                                 0 <br />                                      0.1   1         10          100                                  0   0.5           1         1.5   2 <br />                                            [Inhibitor], &#206;&#188;M                                                      Inhibitor, fold EC50 <br />  <br />  <br />                                                                                                       0   3.5           7        10.5   14 <br />                                                                                                                 [DDU 86439], &#206;&#188;M <br />  <br /> Fig. 4. Chemical targeting TRYS T. brucei.  Chemical structure TRYS inhibitor DDU 86439 (N-(3-(dimethylamino)propyl)-2-(3-(3-fluorophenyl)-1H-indazol-1-yl)acetamide). <br /> B. EC50 values determined DDU 86439 WT (closed circles), SKO (open squares), TRYS-overexpressing (open circles) cDKO cells grown absence tetracycline 2 days prior analysis (closed squares, dotted line). curves non-linear fits data using parameter EC50 equation provided GraFit  Experimental procedures). EC50 values 7.1 &#226;&#171;&#190; 0.2, 1.2 &#226;&#171;&#190; 0.05, 23.3 &#226;&#171;&#190; 0.3 0.46 &#226;&#171;&#190; 0.01 mM determined WT, SKO, TRYS-overexpressing cDKO cell lines respectively. Data mean duplicate <br /> measurements. <br /> C. Analysis intracellular T[SH]2 (closed circles) GSH (open circles) levels T. brucei bloodstream parasites (WT) following incubation compound DDU 86439 (72 h). Data represented percentage thiol levels untreated cells (0.51 0.42 nmol(108 cells)-1 GSH T[SH]2 respectively; Table S1) measurement mean individual measurements. <br />  <br />  <br /> cDKO(C57A) cells absence doxycycline                               logical function remains. researchers remained free parasites 20 days                      suggested ability hydrolyse T[SH]2 com- terminally infected, mouse remained                       ponents, GSH spermidine enable cells parasite-free entire 30 days experiment.                      respond conditions polyamine deprivation (Oza <br /> Western PCR analysis parasites recovered                         et al., 2002b; Fyfe et al., 2008). examine hypoth- infected animals revealed tetracycline control                  esis, cDKO cDKO(C57A) cell lines tested lost mutated TRYS                          relative sensitivity difluoromethylornithine <br /> freely expressed (data shown). evident                  (DFMO) (Fig. 6A), suicide inhibitor ornithine decar- <br /> TRYS-amidase activity essential vivo                 boxylase, rate-determining enzyme polyamine bio- <br /> vitro viability T. brucei, absence activity                   synthesis (Phillips Wang, 1987; Phillips et al., 1988). <br /> retards growth vitro decreases virulence                       primary role TRYS-amidase release <br /> mouse model.                                                                 polyamine stores T[SH]2 times need,                                                                              reasonable assume cells ability <br />                                                                              sensitive DFMO.  cell biological function TRYS-amidase                                                                              line expressing functional TRYS-amidase just <br /> T. brucei? <br />                                                                              sensitive DFMO cell line expressing TRYS-amidase required viability viru-                   &#226;&#8364;&#732;dead&#226;&#8364;&#8482; enzyme (EC50: 17.5 &#226;&#171;&#190; 0.5 16.6 &#226;&#171;&#190; 0.8 mM <br /> lence bloodstream T. brucei, question bio-                     respectively). <br />  <br />                                                                                                                         &#194;&#169; 2009 Authors <br />                                                    Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                                                                                                         Synthetase amidase activity TRYS essential 535 <br />  <br />                                                                                                B                                                                         C <br />                                                                                                                      180 <br />                                  1e10 <br />                                                                                                                      160                                                                 100 <br />                                   1e9 <br /> Cumulative cell numbers, ml-1 <br />  <br />  <br />  <br />  <br />                                                                                                                      140 <br />                                   1e8                                                                                                                                                     80 <br />                                                                                                                      120 <br />  <br />  <br />  <br />  <br />                                                                                                  Thiols, % control <br />  <br />  <br />  <br />  <br />                                                                                                                                                                            Survival, % <br />                                   1e7 <br />                                                                                                                      100 <br />                                                                                                                                                                                           60 <br />                                   1e6                                                                                 80 <br />  <br />                                   1e5                                                                                 60                                                                  40 <br />  <br />                                 10000                                                                                 40 <br />                                                                                                                                                                                           20 <br />                                  1000                                                                                 20 <br />  <br />                                                                                                                        0 <br />                                   100 <br />                                                                                                                                                                                              0 <br />                                         0                   2          4          6     8                                  0       2                           4                                 0           10            20   30 <br />                                                                      Time, days                                                  Time, days                                                                       Time, days <br />  <br /> Fig. 5. vitro vivo characterization TRYS-amidase &#226;&#8364;&#732;dead&#226;&#8364;&#8482; cell line.  growth cDKO(C57A) cell line HMI9-T medium monitored presence (closed circles) absence tetracycline <br /> (open circles, dashed line) arrow indicates point viable cells longer recoverable subcultured 10 days medium containing tetracycline. <br /> B. Intracellular T[SH]2 (closed circles) GSH (open circles) levels cDKO(C57A) cells following removal tetracycline cultures. data point represents means &#226;&#171;&#190; standard deviations triplicate determinations. <br /> C. Groups mice infected WT cDKO(C57A) cells (1 &#194;&#165; 104 parasites). Mice infected tetracycline-treated parasites dosed doxycycline drinking water 3 days prior   infection. Data presented form Kaplan&#226;&#8364;&#8220;Meier survival plot. Symbols: WT, blue; cDKO presence doxycycline, red; cDKO absence doxycycline, green. <br />  <br />  <br />   determine reduced virulence                                                                                    shown dosing mice manner increased <br /> cDKO(C57A) cell line attributed inability                                                                            parasite polyamine levels extent DFMO <br /> access T[SH]2-conjugated polyamines, groups                                                                                         longer cure infection (McCann et al., 1981; <br /> cDKO(C57A)-infected mice given daily bolus                                                                                   Nathan et al., 1981). Similarly, hypothesized spermidine intraperitoneal injection. Previous studies                                                                             increased polyamine levels cDKO(C57A) cells  <br />  <br />                                                                                                                                      B <br />                                                             100                                                                                      100 <br />  <br />  <br />  <br />                                                                 80                                                                                   80 <br />                                             Cell count, % <br />  <br />  <br />  <br />  <br />                                                                                                                                        Survival, % <br />  <br />  <br />  <br />  <br />                                                                 60                                                                                   60 <br />  <br />  <br />  <br />                                                                 40                                                                                   40 <br />  <br />  <br />  <br />                                                                 20                                                                                   20 <br />  <br />  <br />  <br />                                                                 0                                                                                     0 <br />                                                                            1                10                             100                             0   1   2   3                 4       5   6   7        8   9   10 <br />                                                                                       [DFMO], &#206;&#188;M                                                                                         Time, days <br />  <br /> Fig. 6. effect polyamines growth virulence cDKO(C57A) parasites.  EC50 values determined DFMO cDKO (closed circles) cDKO(C57A) cells (closed circles). curves non-linear fits data using parameter EC50 equation provided GraFit  Experimental procedures). EC50 values 17.5 &#226;&#171;&#190; 0.5 16.6 &#226;&#171;&#190; 0.8 mM determined cDKO cDKO(C57A) cell lines respectively. Data mean duplicate measurements. <br /> B. Groups mice infected cDKO cDKO(C57A) cells (1 &#194;&#165; 104 parasites). mice infected tetracycline-treated <br /> parasites dosed doxycycline drinking water. set cDKO cDKO(C57A)-infected mice received daily <br /> intraperitoneal injections spermidine (100 mg kg-1). Data presented form Kaplan&#226;&#8364;&#8220;Meier survival plot. Symbols: cDKO, blue; <br /> cDKO plus spermidine, red; cDKO(C57A), green; cDKO(C57A) plus spermidine, yellow. <br />  <br /> &#194;&#169; 2009 Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />  536 S. Wyllie et al. &#228;&#352;? <br />  <br /> result return levels virulence seen cDKO          high metabolic turnover. Given infections. Mice inoculated cDKO cell line suc-            existing drugs interact directly indirectly T[SH]2 <br /> cumbed infection days 4 5, regardless              metabolism (Fairlamb, 2003), inhibitors TRYS presence absence additional spermidine (Fig. 6B).             prove ideal candidates combination therapy. RNAi  cDKO(C57A) parasites virulent             studies revealed TRYS-depleted T. brucei pro- expressing functional TRYS-amidase,               cyclics significantly susceptible trypanocides, <br /> mice heavily infected days 6 10.               melarsoprol triostam, known act significantly, daily dosing infected mice sper-        T[SH]2 metabolism (Ariyanayagam et al., 2005). addi- <br /> midine absolutely effect virulence             tion, procyclics sensitive cDKO(C57A) cells. failure additional spermidine           redox-cycling drug nifurtimox, currently phase III clinical <br /> enhance virulence cells suggest             trials use African sleeping sickness. Collec- primary function TRYS-amidase enable               tively, findings suggest use drugs target- <br /> access T[SH]2-conjugated polyamines.                             ing TRYS, combination existing drugs, prove <br />    findings bring question hypothesis           effective strategy treating T. brucei infections. <br /> TRYS-amidase plays pivotal role regulation cellular polyamines (Shim Fairlamb, 1988; Tetaud <br /> et al., 1998; Oza et al., 2002b; Fyfe et al., 2008).                                                                     Experimental procedures case, biological function           Cell lines culture conditions <br /> amidase T. brucei? Kinetic analysis recombinant <br />                                                                     Trypanosoma brucei bloodstream-form &#226;&#8364;&#732;single marker&#226;&#8364;&#8482; S427 <br /> T. brucei T. cruzi TRYS shown amidase <br />                                                                     (T7RPOL TETR NEO) knockouts cultured 37&#194;&#176;C <br /> activity enzymes equivalent 1%                                                                     modified HMI9 medium (56 mM 1-thioglycerol substi- synthetase activity optimal assay conditions              tuted 200 mM 2-mercaptoethanol) supplemented (Oza et al., 2002b; 2003). true          2.5 mg ml-1 G418 maintain expression T7 RNA poly- vivo enzyme, difficult amidase        merase tetracycline repressor protein (Hirumi meaningful impact intracellular polyamine               Hirumi, 1989). Cultures initiated 1 &#194;&#165; 105 cells ml-1 <br /> levels. Alternatively, low enzymatic activity recom-         subcultured cell densities approached <br /> binant TRYS-amidase readily explained T[SH]2            1&#226;&#8364;&#8220;2 (&#194;&#165; 106) ml-1. Single marker (WT), SKO, cDKO OE <br />                                                                     cell lines grown continuously presence GspdSH natural substrates                                                                     appropriate drug selection  details). <br /> enzyme. Gram-positive bacteria Mycobacterium                    order examine effects inhibitors growth smegmatis, thiol S-conjugate amidase char-               parasites, triplicate cultures containing inhibitor <br /> acterized specifically hydrolyses thiol-conjugated            seeded 1 &#194;&#165; 105 trypanosomes ml-1. Cell densities <br /> xenobiotics, resulting detoxification xenobiotic          determined using CASY Model TT cell counter recycling thiol (Newton et al., 2000). tempt-      (Sch&#195;&#164;rfe) culture 72 h. EC50 values determined <br /> ing suggest TRYS-amidase play similar role            using following parameter equation non-linear <br />                                                                     regression using GraFit: T. brucei enzyme highly selective S-conjugates T[SH]2 formed trypanothione                                                       100 <br />                                                                                            y= <br />                                                                                                         &#226;&#381;&#382; <br />                                                                                                             m <br /> S-transferase (Vickers Fairlamb, 2004). Studies                                                                                                 1+ &#226;&#381;&#8250; <br /> underway test validity hypothesis.                                          &#226;&#381;? EC50 &#226;&#381;&#160; <br /> irrefutable study TRYS-amidase           experimental data corrected background <br /> viable drug target African trypanosome.                      cell density expressed percentage uninhibited <br />                                                                     control cell density. equation   represents inhibitor <br />                                                                     concentration m slope factor. <br /> Implications parasite chemotherapy <br />  study, TRYS chemically genetically <br />                                                                     Generation knockout, overexpression recovery <br /> validated drug target bloodstream T. brucei.                                                                     constructs shown TRYS null trypanosomes unable establish infection mice chemical targeting          primers used summarized Table 1 enzyme leads parasite death. potency          designed using T. brucei trypanothione synthetase <br /> lead TRYS inhibitor bloodstream trypanosomes                (TRYS) sequence GeneDB (Tb927.2.4370) template. <br />                                                                     accuracy assembled constructs verified (EC50 7 mM) compares favourably eflornithine <br />                                                                     sequencing. TRYS gene replacement cassettes gener- <br /> (EC50 17.5 mM, Fig. 6A), current line drug used                                                                     ated amplifying region DNA encompassing treatment HAT. Like eflornithine, DDU 86439           5&#226;&#8364;&#178;-UTR, open reading frame (ORF) 3&#226;&#8364;&#178;-UTR T. brucei <br /> rapidly cidal decrease intracellular T[SH]2              TRYS genomic DNA primers 5&#226;&#8364;&#178;UTR-NotI_s content compatible dilution cell division            3&#226;&#8364;&#178;UTR-NotI_as, using Pfu polymerase. sequence  <br />                                                                                                                 &#194;&#169; 2009 Authors <br />                                            Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                                 Synthetase amidase activity TRYS essential 537 <br />  <br /> Table 1. Upper case letters refer nucleotides corresponding gene sequences T. brucei; lower case refers additional sequences used generating constructs. <br />  <br /> Primer                                     Primer sequence <br />  <br /> 5&#226;&#8364;&#178;UTR-NotI_s                                    5&#226;&#8364;&#178;-ataagaatgcggccgcTGTGGTTGTTGTTTC-3&#226;&#8364;&#178; <br /> 5&#226;&#8364;&#178;UTR-HindIII/PmeI_as                           5&#226;&#8364;&#178;-gtttaaacttacggaccgtcaagcttTTGTTTCAATTGCTTTTCC-3&#226;&#8364;&#178; <br /> 3&#226;&#8364;&#178;UTR-PmeI/BamHI_s                              5&#226;&#8364;&#178;-gacggtccgtaagtttaaacggatccCACAACCCTTCCGTTTTG-3&#226;&#8364;&#178; <br /> 3&#226;&#8364;&#178;UTR-NotI_as                                   5&#226;&#8364;&#178;-ataagtaagcggccgcGGAATAAACATAAAGC-3&#226;&#8364;&#178; <br /> TbTRYS-HindIII_s                                5&#226;&#8364;&#178;-cggaaggagaaagcttatgggcagcagccat-3&#226;&#8364;&#178; <br /> TbTRYS-BamHI_as                                 5&#226;&#8364;&#178;-ggatccCTACATTTGAATACGTACGGGACCAAACGGAGATTCGAGCCCAGTGATGAGCTT-3&#226;&#8364;&#178; <br /> TbTRYS(C57A) mut_s                              5&#226;&#8364;&#178;-cttttctgcggtttcaaataccaagctgtagaattt-3&#226;&#8364;&#178; <br /> TbTRYS(C57A) mut_as                             5&#226;&#8364;&#178;-aaattctacagcttggtatttgaaaccgcagaaaag-3&#226;&#8364;&#178; <br />  <br /> Restriction endonuclease sites underlined mutations used generate amidase-dead TRYS indicated bold. <br />  <br />  <br />  <br />  used template amplification individual          pLew100_TbTRYS mutated version vector <br /> regions used assembly replacement cassettes                pLew100_TbTRYS(C57A) cultured presence taining selectable drug-resistance genes puromycin                   2.5 mg ml-1 blasticidin addition puromycin. Prior N-acetyl transferase (PAC) hygromycin phosphotrans-                  removal remaining TRYS allele, expression ferase (HYG), exactly previously described (Martin                recombinant TRYS proteins induced addition Smith, 2005).                                                            tetracycline (2 mg ml-1, 72 h) culture medium. cDKO <br />    generate recovery construct pLew100_TbTRYS,                cell line finally generated following replacement TRYS ORF T. brucei amplified genomic DNA                   final TRYS allele HYG. resulting cell line using TbTRYS-HindIII sense TbTRYS-BamHI antisense                    cultured presence hygromycin (4.0 mg ml-1) primers, cloned pCR-Blunt II TOPO (Invitrogen).             addition previously described drugs. TRYS <br /> pCR-Blunt II-TOPO-TbTRYS construct digested                     overexpression cell line generated directly trans- HindIII BamHI resulting fragment ligated           forming single marker bloodstream parasites HindIII/BamHI cloning site modified pLew100                     pLew100_TbTRYS vector inducing recombinant protein <br /> tetracycline-inducible expression vector (Wirtz et al., 1999)            expression addition tetracycline. step contains blasticidin S transferase (BSD) select-            generation transgenic cell lines, parasites able gene marker (kindly supplied Dr Kirstee Martin).             cloned serial dilution. <br /> resulting rescue vector used TRYS overex- <br /> pression vector single marker T. brucei bloodstream <br /> parasites.                                                               Southern blot analyses transgenic T. brucei cell lines <br />    additional recovery construct generated containing mutated version T. brucei TRYS gene. Site-directed              ORF T. brucei TRYS amplified PCR (using mutagenesis carried following QuikChange&#194;&#174; pro-               primers previously described cloning TbTRYS tocol (Stratagene) using KOD HotStart DNA poly-                  pLew100-BSD) PCR DIG Probe Synthesis Kit <br /> merase (Novagen). Using pLew100_TbTRYS construct                     (Roche). resulting digoxigenin-labelled TbTRYS product template, C mutation introduced position 57           used probe. Samples genomic DNA (5 mg) T. brucei TRYS generated PCR resulting                  single marker transgenic cell lines digested modified construct &#226;&#8364;&#8220; pLew100_TbTRYS(C57A).                               restriction endonuclease PstI, digestion products                                                                          separated 0.8% agarose gel transferred                                                                          positively charged nylon membrane (Roche). mem- <br /> Generation transgenic T. brucei cell lines                            brane hybridized overnight DIG Easy Hyb solution <br />                                                                          (Roche) 42&#194;&#176;C DIG-labelled TRYS ORF probe (2 ml <br /> Knockout, recovery overexpression constructs pre-               PCR product). Following hybridization, membranes pared using QIAprep Miniprep Plasmid Kit (Qiagen). DNA                   washed twice low stringency conditions (25&#194;&#176;C, 2 &#194;&#165; 5 min, digested NotI, ethanol precipitated redissolved             2&#194;&#165; SSC 0.1% SDS) twice high stringency condi- sterile water final concentration 1 mg ml-1. Trypano-         tions (68&#194;&#176;C, 2 &#194;&#165; 15 min, 0.5&#194;&#165; SSC 0.1% SDS), 1&#194;&#165; <br /> somes electroporated 5 mg DNA using reagents                SSC comprises 150 mM sodium chloride 50 mM sodium Human T cell Nucleofector kit manufacturers&#226;&#8364;&#8482;             acetate, pH 7.0. Bound probe detected using DIG <br /> instructions using programme X-001 Nucleofector               immunological detection kit (Roche) manufacturers&#226;&#8364;&#8482; <br /> II electroporator (Amaxa, Cologne, Germany) (Burkard et al.,             instructions. <br /> 2007). <br />    cDKO TRYS generated sequentially replac- <br /> ing endogenous TRYS genes drug-resistance genes.                Western blot analysis T. brucei cell lysates TRYS allele replaced drug-resistance <br /> gene PAC resulting SKO cell line cultured              Polyclonal antisera T. brucei TRYS raised continuous presence 0.1 mg ml-1 puromycin. SKO                adult male Wistar rats. initial injection 100 mg purified <br /> cells transformed recovery vector              antigen, emulsified complete Freund&#226;&#8364;&#8482;s adjuvant, fol- <br />  <br /> &#194;&#169; 2009 Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />  538 S. Wyllie et al. &#228;&#352;? <br />  <br /> lowed identical booster injections antigen emulsified     vivo studies Freund&#226;&#8364;&#8482;s incomplete adjuvant 2 week intervals. <br />    Trypanosoma brucei cell extracts (1 &#194;&#165; 107 parasites        Wild-type transgenic bloodstream T. brucei parasites lane) separated SDS/PAGE subsequently               cultured absence selectable drugs (hygromy- <br /> transferred nitrocellulose. blocking 7%             cin, blasticidin, puromycin G418) 24 h prior infec- <br /> skimmed milk phosphate buffered saline (PBS) 1 h,            tion mice. time, cDKO cells grown blots incubated T. brucei TRYS (1:700 dilu-        presence absence 1 mg ml-1 tetracycline. para- <br /> tion) T. brucei PTR1 (1:500) (Sienkiewicz et al., 2008)          sites used infect groups mice (dosed polyclonal antiserum 1 h, washed PBS containing 0.1%         doxycycline respectively) single intraperito- <br /> (v/v) Tween-20, incubated secondary anti-           neal injection 104 parasites 0.2 ml HMI9-T medium. <br /> body [rabbit anti(rat IgG)] (Dako, Ely, UK; 1:10 000 dilution).     plus doxycycline group animals dosed doxy- <br /> Immunoblots developed using ECL plus (enhanced             cycline drinking water (0.2 mg ml-1 5% sucrose <br /> chemiluminescence) GE Healthcare (Piscat-               solution) 5 days prior infection freshly prepared <br /> away, NJ, USA).                                                     second day duration experiment. Animals <br />                                                                     inspected daily clinical signs infection wet <br />                                                                     smears tail blood examined microscopically. Parasi- <br /> Drug discovery                                                      taemia determined using Neubauer haemocytometer, <br />                                                                     previously described (Sienkiewicz et al., 2008). Mice high-throughput screening campaign 63 000 compounds            exceeded parasitaemia &gt; 108 ml-1 humanely killed, <br /> led identification novel chemical classes      prior experience indicated animals T. brucei TRYS inhibitor. Chemical development               succumb overwhelming infection following day. lead compounds led identification com- <br /> pound DDU 86439 (N-(3-(dimethylamino)propyl)-2-(3-(3- <br /> fluorophenyl)-1H-indazol-1-yl)acetamide) (patent pending)           Acknowledgements inhibited recombinant TRYS potency 0.045 mM inhibited growth bloodstream trypano-           appreciation goes Adel Ibrahim University <br /> somes EC50 6.9 &#226;&#171;&#190; 0.2 mM. DDU 86439 pre-              Dundee Cloning Service help site-directed <br /> pared synthetic steps indazole. Briefly, indazole      mutagenesis cloning pLew100 Dr Natasha Sien- iodinated position, previously described        kiewicz helpful advice concerning generation trans- <br /> (Edwards et al., 2003). resultant aryl iodide served            genic organisms. thank Dr Paul Wyatt, Director substrate Suzuki coupling reaction                Dundee Drug Discovery Unit invaluable advice 3-fluorophenylboronic acid analogous manner           medicinal chemistry presented paper. work previously described (El Kazzouli et al., 2005). indazole       funded grants Wellcome Trust (WT 079838; WT N 1-alkylated treatment sodium hydride         077705; WT 083481). <br /> ethyl bromoacetate. resulting crude ester hydro- <br /> lysed treatment sodium hydroxide water/ <br /> tetrahydrofuran. Following acidic workup, product               References <br /> carboxylic acid purified silica column chromatography. amide synthesis accomplished standard carbo-            Alibu, V.P., Richter, C., Voncken, F., Marti, G., Shahi, S., <br /> diimide chemistry utilizing N-(3-Dimethylaminopropyl)-                 Renggli, C.K., et al. (2006) role Trypanosoma brucei <br /> N&#226;&#8364;&#178;-ethylcarbodiimide,        1-Hydroxybenzotriazole,      N,N-         MRPA melarsoprol susceptibility. Mol Biochem Parasitol <br /> Diisopropylethylamine 3-(dimethylamino)-1-propylamine              146: 38&#226;&#8364;&#8220;44. furnish title compound, purified silica         Ariyanayagam, M.R., Fairlamb, H. (2001) Ovothiol column chromatography. details chemical synthesis           trypanothione antioxidants trypanosomatids. Mol inhibitors published                Biochem Parasitol 115: 189&#226;&#8364;&#8220;198. <br />                                                                     Ariyanayagam, M.R., Oza, S.L., Guther, M.L., Fairlamb, <br />                                                                        H. (2005) Phenotypic analysis trypanothione syn- <br /> Analysis intracellular thiols                                       thetase knockdown African trypanosome. Biochem J <br />                                                                        391: 425&#226;&#8364;&#8220;432. determine effect inhibitor DDU 86439 intracellu-       Bacchi, C.J., Yarlett, N. (1995) Polyamine metabolism. lar thiol levels, cultures containing 1 &#194;&#165; 105 bloodstream trypa-       Biochemistry Molecular Biology Parasites. Marr, <br /> nosomes ml-1 incubated varying concentrations             J.J., M&#195;&#188;ller, M. (eds). London: Academic Press, pp. <br /> inhibitor DDU 86439 equivalent 0.5, 1.0, 1.5 2&#194;&#165;             119&#226;&#8364;&#8220;131. <br /> previously determined EC50 (6.9 &#226;&#171;&#190; 0.2 mM). Following incuba-        Barrett, M.P., Fairlamb, H. (1999) biochemical <br /> tion 72 h, cells (1 &#194;&#165; 108) collected centrifugation        basis arsenical-diamidine cross-resistance African <br /> (900 g, 10 min, 4&#194;&#176;C), washed ice-cold PSG buffer               trypanosomes. Parasitol Today 15: 136&#226;&#8364;&#8220;140. <br /> (PBS, pH 8.0, 1.5% (w/v) glucose 0.5 mg ml-1 BSA)           Bateman, , Rawlings, N.D. (2003) CHAP domain: derivatised monobromobimane, described previously              large family amidases including GSP amidase pep- <br /> (Shim Fairlamb, 1988). Acid-soluble thiols sepa-              tidoglycan hydrolases. Trends Biochem Sci 28: 234&#226;&#8364;&#8220;237. <br /> rated <span id='am-19' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-20' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-23' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="ion" datatype="xsd:string"></span>ion</span>-paired, reverse phase HPLC ion-paired            Burkard, G., Fragoso, C.M., Roditi,  (2007) Highly effi- <br /> Ultrasphere C18 column using Dionex Ultimate 3000 instru-            cient stable transformation bloodstream forms Trypa- <br /> ment fitted Dionex RF-2000 fluorometer.                         nosoma brucei. Mol Biochem Parasitol 153: 220&#226;&#8364;&#8220;223. <br />  <br />                                                                                                                 &#194;&#169; 2009 Authors <br />                                            Journal compilation &#194;&#169; 2009 Blackwell Publishing  Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                         Synthetase amidase activity TRYS essential 539 <br />  <br /> Chang, T., Milne, K.G., Guther, M.L.S., Smith, T.K.,              Nathan, H.C., Amole, B.O., et al. (1981) studies   Ferguson, M J. (2002) Cloning Trypanosoma brucei               difluoromethylornithine African trypanosomes. Med Biol <br />   Leishmania major genes encoding GlcNAc-                     59: 434&#226;&#8364;&#8220;440. <br />   <span id='am-6' about='obo:IMR_0001651' typeof='owl:Thing obo:IMR_0001650 obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-7' property="rdfs:label" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="MPI" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="phosphoinositide" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="KEGG:C00626" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasExactSynonym" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-13' property="rdfs:label" content="phosphatidylinositol" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:id" content="IMR:0001651" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasExactSynonym" content="MPI" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasExactSynonym" content="phosphoinositide" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasExactSynonym" content="monophosphoinositide" datatype="xsd:string"></span>phosphatidylinositol</span> n-acetylase glycosylphosphati-         Martin, K., Smith, T.K. (2005) <span id='am-48' about='obo:IMR_0200177' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-49' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:id" content="IMR:0200177" datatype="xsd:string"></span><span id='am-51' property="rdfs:label" content="myo-Inositol" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasDbXref" content="KEGG:C00137" datatype="xsd:string"></span>myo-inositol</span>-1- <br />   dylinositol biosynthesis essential african           phosphate synthase gene essential Trypanosoma <br />   sleeping sickness parasite. J Biol Chem 277: 50176&#226;&#8364;&#8220;                 brucei. Biochem Soc Trans 33: 983&#226;&#8364;&#8220;985. <br />   50182.                                                            Mukhopadhyay, R., Dey, S., Xu, N., Gage, D., Lightbody, J., <br /> Comini, M , Guerrero, S , Haile, S., Menge, U., Lunsdorf,         Ouellette, M., Rosen, B.P. (1996) Trypanothione  <br />   H., Floh&#195;&#169;, L. (2004) Validation Trypanosoma brucei           production resistance antimonials arsenicals   trypanothione synthetase drug target. Free Radic Biol            Leishmania. Proc Natl Acad Sci USA 93: 10383&#226;&#8364;&#8220;10387. <br />   Med 36: 1289&#226;&#8364;&#8220;1302.                                                Nathan, H.C., Bacchi, C.J., Hutner, S.H., Rescigno, D., Croft, S.L., Sundar, S., Fairlamb, H. (2006) Drug               Sjoerdsma,  (1981) Antagonism polyamines   Resistance Leishmaniasis. Clin Microbiol Rev 19: 111&#226;&#8364;&#8220;            curative effects difluoromethylornithine Trypano- <br />   126.                                                                soma brucei brucei infections. Biochem Pharmacol 30: <br /> Dormeyer, M., Reckenfelderbaumer, N., Ludemann, H.,               3010&#226;&#8364;&#8220;3013. <br />   Krauth-Siegel, R.L. (2001) Trypanothione-dependent syn-           Newton, G.L., Av-Gay, Y., Fahey, R.C. (2000) novel <br />   thesis deoxyribonucleotides Trypanosoma brucei                mycothiol-dependent detoxification pathway mycobacte- <br />   ribonucleotide reductase. J Biol Chem 276: 10602&#226;&#8364;&#8220;10606.             ria involving mycothiol S-conjugate amidase. Biochemistry <br /> Edwards, M.L., Cox, P.J., Amendola, S., Deprets, S.D.,                39: 10739&#226;&#8364;&#8220;10746. <br />   Gillespy, T , Edlin, C.D., et al. (2003) Benzimidazoles         Opperdoes, F.R., Baudhuin, P., Coppens, , Roe, C., <br />   analogues use protein kinases inhibitors.          Edwards, S.W., Weijers, P.J., Misset, O. (1984) Puri- <br />   Aventis Pharmaceuticals  Patent WO/2003/035065.                 fication, morphometric analysis, characterization El Kazzouli, S., Bouissane, L., Khoulli, M., Guillaumet, G.       glycosomes (microbodies) protozoan hemoflagellate <br />   (2005) Synthesis 4-substituted 3,4-disubstituted             Trypanosoma brucei. J Cell Biol 98: 1178&#226;&#8364;&#8220;1184. <br />   indazole derivatives palladium-mediated cross-coupling         Oza, S.L., Ariyanayagam, M.R., Fairlamb, H. (2002a) <br />   reactions. Tetrahedron Lett 46: 6163&#226;&#8364;&#8220;6167.                          Characterization recombinant glutathionylsper <br /> </body></html>